1 Min Read
June 19 (Reuters) - MAUNA KEA TECHNOLOGIES SAS:
* MAUNA KEA TECHNOLOGIES: NEW PUBLICATION CONFIRMS BENEFITS OF USING CELLVIZIO FOR CHARACTERIZING UPPER URINARY TRACT CANCER Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.